Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil H Shear

Showing results (21-30 of 192) with videos related to

Pageof 20
Sort By:
Dermatologic Clinics|July 6, 2015
Granulomatous Drug EruptionsRoni P Dodiuk-Gad, Neil H Shear
Archives of Dermatology|February 18, 2004
Is a drug alone sufficient to cause the drug hypersensitivity syndrome?Gavin A E Wong, Neil H Shear
Drugs & Aging|August 13, 2017
Cutaneous Drug Reactions in the ElderlyJames W S Young, Neil H Shear
Dermatologic Clinics|April 20, 2005
Adverse drug interactions and reactions in dermatology: current issues of clinical relevanceGavin A E Wong, Neil H Shear
The Journal of Dermatological Treatment|March 14, 2022
Time to codify a challenge in communicationSylvia Aide Martinez-Cabriales, Neil H Shear
Contact Dermatitis|March 5, 2004
Melkersson-Rosenthal syndrome associated with allergic contact dermatitis from octyl and dodecyl gallatesGavin A E Wong, Neil H Shear
Medical Hypotheses|August 18, 2019
Quantification of randomness (Entropy) as a clinical tool to assess the severity of skin diseaseAlina Breslavets, Maksym Breslavets, Neil H Shear
Journal of the American Academy of Dermatology|July 23, 2013
Treatment of mucous membrane pemphigoid with rituximabKara Heelan, Scott Walsh, Neil H Shear
Drug Safety|October 17, 2002
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experienceRachel Forman, Gideon Koren, Neil H Shear
Journal of Cutaneous Medicine and Surgery|September 4, 2019
What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?Sam Hanna, Catherine Zip, Neil H Shear
Pageof 20

Showing results (21-30 of 192) with videos related to

Sort By:
Pageof 20
Dermatologic Clinics|July 6, 2015
Granulomatous Drug EruptionsRoni P Dodiuk-Gad, Neil H Shear
Archives of Dermatology|February 18, 2004
Is a drug alone sufficient to cause the drug hypersensitivity syndrome?Gavin A E Wong, Neil H Shear
Drugs & Aging|August 13, 2017
Cutaneous Drug Reactions in the ElderlyJames W S Young, Neil H Shear
Dermatologic Clinics|April 20, 2005
Adverse drug interactions and reactions in dermatology: current issues of clinical relevanceGavin A E Wong, Neil H Shear
The Journal of Dermatological Treatment|March 14, 2022
Time to codify a challenge in communicationSylvia Aide Martinez-Cabriales, Neil H Shear
Contact Dermatitis|March 5, 2004
Melkersson-Rosenthal syndrome associated with allergic contact dermatitis from octyl and dodecyl gallatesGavin A E Wong, Neil H Shear
Medical Hypotheses|August 18, 2019
Quantification of randomness (Entropy) as a clinical tool to assess the severity of skin diseaseAlina Breslavets, Maksym Breslavets, Neil H Shear
Journal of the American Academy of Dermatology|July 23, 2013
Treatment of mucous membrane pemphigoid with rituximabKara Heelan, Scott Walsh, Neil H Shear
Drug Safety|October 17, 2002
Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experienceRachel Forman, Gideon Koren, Neil H Shear
Journal of Cutaneous Medicine and Surgery|September 4, 2019
What Is the Risk of Harm Associated With Topical Calcineurin Inhibitors?Sam Hanna, Catherine Zip, Neil H Shear
Pageof 20